List of Excipients in API BEXAROTENE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BEXAROTENE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Bausch Health US LLC | TARGRETIN | bexarotene | 0187-5525 | ALCOHOL | |
Bausch Health US LLC | TARGRETIN | bexarotene | 0187-5525 | BUTYLATED HYDROXYTOLUENE | |
Bausch Health US LLC | TARGRETIN | bexarotene | 0187-5525 | HYDROXYPROPYL CELLULOSE | |
Bausch Health US LLC | TARGRETIN | bexarotene | 0187-5525 | POLYETHYLENE GLYCOL 400 | |
Bausch Health US LLC | TARGRETIN | bexarotene | 0187-5526 | 1,4-SORBITAN | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BEXAROTENE
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 | BUTYLATED HYDROXYANISOLE |
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 | FERROSOFERRIC OXIDE |
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 | GELATIN |
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 | GLYCERIN |
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 | HYPROMELLOSE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BEXAROTENE
Excipient focus: 1,4-SORBITAN
BEXAROTENE drug variants containing 1,4-SORBITAN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5526 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
Oceanside Pharmaceuticals | bexarotene | 68682-003 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing 1,4-SORBITAN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
BEXAROTENE drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
BEXAROTENE drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
AvKARE | bexarotene | 42291-072 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-1250 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
BEXAROTENE drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AvKARE | bexarotene | 42291-072 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-1250 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
BEXAROTENE drug variants containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
BEXAROTENE drug variants containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
BEXAROTENE drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5526 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
BEXAROTENE drug variants containing DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
BEXAROTENE drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
BEXAROTENE drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
BEXAROTENE drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
BEXAROTENE drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
AvKARE | bexarotene | 42291-072 |
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
BEXAROTENE drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
AvKARE | bexarotene | 42291-072 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN HYDROLYZATE
BEXAROTENE drug variants containing GELATIN HYDROLYZATE
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing GELATIN HYDROLYZATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN TYPE B BOVINE
BEXAROTENE drug variants containing GELATIN TYPE B BOVINE
Company | Ingredient | NDC |
---|---|---|
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing GELATIN TYPE B BOVINE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
BEXAROTENE drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
BEXAROTENE drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
BEXAROTENE drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
AvKARE | bexarotene | 42291-072 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
BEXAROTENE drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
AvKARE | bexarotene | 42291-072 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-1250 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
BEXAROTENE drug variants containing LECITHIN, SOYBEAN
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing LECITHIN, SOYBEAN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
BEXAROTENE drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
Oceanside Pharmaceuticals | bexarotene | 68682-003 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
AvKARE | bexarotene | 42291-072 |
>Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
BEXAROTENE drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
BEXAROTENE drug variants containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
BEXAROTENE drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
BEXAROTENE drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
BEXAROTENE drug variants containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POLYSORBATE 20
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ACETATE PHTHALATE
BEXAROTENE drug variants containing POLYVINYL ACETATE PHTHALATE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POLYVINYL ACETATE PHTHALATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
BEXAROTENE drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
AvKARE | bexarotene | 42291-072 |
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
Oceanside Pharmaceuticals | bexarotene | 68682-003 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
BEXAROTENE drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
BEXAROTENE drug variants containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
BEXAROTENE drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
AvKARE | bexarotene | 42291-072 |
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
BEXAROTENE drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
AvKARE | bexarotene | 42291-072 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-1250 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN
BEXAROTENE drug variants containing SORBITAN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
AvKARE | bexarotene | 42291-072 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-1250 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing SORBITAN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
BEXAROTENE drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION
BEXAROTENE drug variants containing SORBITOL SOLUTION
Company | Ingredient | NDC |
---|---|---|
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing SORBITOL SOLUTION
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5525 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
BEXAROTENE drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
Amneal Pharmaceuticals NY LLC | bexarotene | 69238-2088 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
BEXAROTENE drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bexarotene | 0054-0399 |
Bausch Health US LLC | bexarotene | 0187-5526 |
Mylan Pharmaceuticals Inc | bexarotene | 0378-6955 |
Upsher-Smith Laboratories Inc | bexarotene | 0832-0285 |
AvKARE | bexarotene | 42291-072 |
>Company | >Ingredient | >NDC |
BEXAROTENE drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | bexarotene | 0187-5525 |
Actavis Pharma Inc | bexarotene | 0591-2832 |
Ascent pharmaceutical Inc | bexarotene | 43602-176 |
ANI Pharmaceuticals Inc | bexarotene | 43975-315 |
Oceanside Pharmaceuticals | bexarotene | 68682-002 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.